About Marcelo

Dr. Marcelo Addas-Carvalho received his undergraduate degree in Medicine from the State University of Campinas (1987), medical residency in Clinical Medicine with a concentration in Hematology and Hemotherapy (1991), master degree in Medical Clinic from the Faculty of Medical Sciences (FCM) of UNICAMP (1997) and a doctorate in Clinical Medicine from the FCM of UNICAMP (2005).

He is a specialist in hospital and health management with experience in blood bank management.

Dr. Addas-Carvalho is currently coordinator of the FCM / UNICAMP professional master's program in Hemotherapy, specialist consultant at the Brazilian Ministry of Health and director at Blood Center of Campinas/UNICAMP.

He has experience in Medicine, with emphasis in Hematology and Hemotherapy, working mainly on the following topics: hemotherapy, hematology, transfusion medicine, management of hemotherapy services, adverse effects to transfusion and production and quality control of blood components.

This speaker will be presenting at the following session(s)

  • Prevention interventions

    Ballroom 3

    Day: 2 November

    Time: 14:00

    Chair: Dr. Amr Kandeel, Ministry of Health, Egypt and Dr. Mark Jacobs, World Health Organization


    • Viral hepatitis prevention efforts in Egypt – successes and challenges.
    • Dr. Amr Kandeel, Ministry of Health, Egypt
    • WHO Injection Safety Project.
    • Dr. Arshad Altaf, World Health Organization
    • Implementing injection safety at the country level: challenges and opportunities.
    • Dr. Huma Qureshi, Pakistan Health Research Council
    • Towards zero transmission of HBV from mother to child: new data and the SHIELD project.
    • Dr. Jinlin Hou, Nanfang Hospital, China
    • HCV prevention among people who use drugs: evidence and ways forward.
      Dr. Niklas Luhmann, Médecins du Monde
    • Blood safety and hepatitis.
    • Dr. Marcelo Addas-Carvalho, Blood Center of Campinas/UNICAMP
    • Q & A session.

    Session objectives:

    • Discuss different core areas of viral hepatitis prevention.
    • Hear country examples of good practice for health facility injection safety, vertical transmission and blood product safety.